Evidence map›Paper›PMID 41463121›Full record

ArticleBiomedicines2025

Proteomics Reveals Differential Diagnosis Biomarkers Between Sepsis and Hemophagocytic Syndrome.

David Martin-Pestana, Mikel Azkargorta, Francisco Javier Pilar-Orive, Silvia Redondo, Janire Urrutia, Cristina Calvo, Felix Elortza, Itziar Astigarraga, Susana Garcia-Obregon

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

David Martin-PestanaPediatric Oncology Group, Biobizkaia Health Research Institute, 48903 Barakaldo, Spain.ORCID 0009-0004-1480-6352
Mikel AzkargortaProteomics Platform, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), CIBERehd, Bizkaia Science and Technology Park, 48160 Derio, Spain.
Francisco Javier Pilar-OrivePediatric Critical Care Service, Hospital Universitario Cruces, 48903 Barakaldo, Spain.ORCID 0000-0003-3766-2158
Silvia RedondoPediatric Critical Care Service, Hospital Universitario Cruces, 48903 Barakaldo, Spain.
Janire UrrutiaPediatric Oncology Group, Biobizkaia Health Research Institute, 48903 Barakaldo, Spain.ORCID 0000-0002-8546-292X
Cristina CalvoPediatric Critical Care Service, Hospital Universitario Donostia, 20014 San Sebastián, Spain.
Felix ElortzaProteomics Platform, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), CIBERehd, Bizkaia Science and Technology Park, 48160 Derio, Spain.ORCID 0000-0001-8839-5438
Itziar AstigarragaPediatric Oncology Group, Biobizkaia Health Research Institute, 48903 Barakaldo, Spain.ORCID 0000-0002-5012-0137
Susana Garcia-ObregonPediatric Oncology Group, Biobizkaia Health Research Institute, 48903 Barakaldo, Spain.ORCID 0000-0002-8102-5597

Funding

Basque Government 2012111052Basque Government 2019111056Basque Government SAIO10-PE10BF02Basque Government SAIO12-PE12BF002Fundación Severo Ochoa SEV-2016-0644ProteoRed Grant PRB3 IPT17/0019University of the Basque Country US10/02
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

hemophagocytic lymphohistiocytosissepsisserum proteomics

Identifiers

PMID41463121
PMCPMC12731200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.